Latest filing published 13 Feb 2018 for ICU Medical Inc/de.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -3.1%Entry US$37.42 · Close at T+365 US$36.25
- -2.8%Entry US$35.82 · Close at T+365 US$34.80
- +22.2%Entry US$30.86 · Close at T+365 US$37.72
- +32.5%Entry US$26.68 · Close at T+365 US$35.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven Riggs: trading record in brief
Steven Riggs discloses dealings in ICU Medical Inc/de to SEC (Form 4). We count 139 filings; the first trade dates from 14 February 2007 and the latest from 11 February 2018.
The open-market side counts 4 purchases for €18k alongside 67 sales for €27.8M. Sales outweigh purchases by €27.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 56 share grants and 12 option exercises.
The median purchase comes to €4,536. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 25% of cases; the median change was -4.6%. This is a record of the past, not a forecast.
The record was last updated on 13 February 2018 with an option exercise in ICU Medical Inc/de. The most recent open-market purchase was published on 17 August 2009, 6,292 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven Riggs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,355 shares0Common StockSEC:0001189724-18-000004:0
- 469 shares0Common StockSEC:0001189724-18-000004:1
- 834 shares0Common StockSEC:0001189724-18-000002:0
- 314 shares0Common StockSEC:0001189724-18-000002:1
- 16,250 shares@ US$58.793.8% of flowCommon StockSEC:0001189724-17-000003:0
- 4,500 shares@ US$151.392.7% of flowCommon StockSEC:0001189724-17-000003:1
- 11,750 shares@ US$152.237.1% of flowCommon StockSEC:0001189724-17-000003:2
- 15,000 shares@ US$58.793.5% of flowCommon StockSEC:0001189724-17-000003:3
- 4,796 shares@ US$151.492.9% of flowCommon StockSEC:0001189724-17-000003:4
- 10,204 shares@ US$152.206.2% of flowCommon StockSEC:0001189724-17-000003:5
- 507 shares@ US$145.700.3% of flowCommon StockSEC:0001189724-17-000002:1
- 1,354 shares0Common StockSEC:0001189724-17-000002:0
- 834 shares0Common StockSEC:0001189724-17-000001:0
- 355 shares0Common StockSEC:0001189724-17-000001:1
- 703 shares@ US$121.320.3% of flowCommon StockSEC:0001189724-16-000017:0
- 675 shares@ US$121.350.3% of flowCommon StockSEC:0001189724-16-000017:1
- 13,634 shares@ US$58.793.0% of flowCommon StockSEC:0001189724-16-000017:2
- 10,250 shares@ US$121.764.7% of flowCommon StockSEC:0001189724-16-000017:3
- 3,384 shares@ US$122.061.6% of flowCommon StockSEC:0001189724-16-000017:4
- 12,833 shares@ US$58.792.8% of flowCommon StockSEC:0001189724-16-000017:5
- 11,333 shares@ US$121.765.2% of flowCommon StockSEC:0001189724-16-000017:6
- 1,500 shares@ US$122.060.7% of flowCommon StockSEC:0001189724-16-000017:7
- 11,957 shares@ US$58.792.6% of flowCommon StockSEC:0001189724-16-000017:8
- 2,460 shares@ US$61.760.6% of flowCommon StockSEC:0001189724-16-000017:9
- 11,717 shares@ US$121.745.4% of flowCommon StockSEC:0001189724-16-000017:10
25 of 138 declarations